855 The use of R-met Hu 6-CSF in combination with high and standard doses of Ifosfamide and doxorubicin in the patients with advanced soft tissue sarcoma
β Scribed by M. Erkisi; E. Erkurt; S. Ozbarlas; R. Burgut; F. Doran; E. Seyrek
- Book ID
- 116167601
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 165 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a phase II study, 42 patients with advanced soft-tissue sarcoma were treated with ifosfamide by 24-h infusion and mesna by 4-h IV bolus, repeated every 3 weeks. Ten patients received ifosfamide 5.0 g/m2, 20 had the dosage increased to 8.0 g/m2, and 12 received 8.0 g/m2 from the outset. Mesna was
## BACKGROUND. Successful chemotherapy for patients with soft tissue sarcoma (STS) has been limited by a lack of active drugs. The most effective single agents are doxorubicin, dacarbazine, and, more recently, ifosfamide. Previously the most widely used combination has been CYVADIC (cyclophosphami